Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Elixir Capital
Join Channel
Consolidated Standalone

Elixir Capital

₹115.9 5.5 | 5%

Market Cap ₹67 Cr.

Stock P/E 4.3

P/B 1.4

Current Price ₹115.9

Book Value ₹ 83.5

Face Value 10

52W High ₹115.9

Dividend Yield 1.08%

52W Low ₹ 37

Edit Ratio

Elixir Capital Research see more...

Overview Inc. Year: 1994Industry: Finance - Investment

Elixir Capital Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Elixir Capital Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 1 9 -4 -4 0 -1 5 6 6 16
Other Income 0 1 0 0 0 0 0 0 0 1
Total Income 1 10 -3 -3 0 -0 5 6 6 17
Total Expenditure 1 2 1 1 1 2 2 2 2 2
Operating Profit 0 9 -5 -5 -1 -2 4 5 5 15
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 1 -0 0
Profit Before Tax -0 8 -5 -5 -1 -2 3 5 4 14
Provision for Tax -0 2 0 0 -0 0 0 1 1 3
Profit After Tax 0 7 -5 -5 -1 -3 3 4 3 11
Adjustments 0 -2 0 0 0 1 -1 -1 -1 -3
Profit After Adjustments 0 5 -5 -5 -1 -2 2 3 2 8
Adjusted Earnings Per Share 0 8.4 -8.5 -8.5 -1.8 -3.4 3.9 5.4 4.1 13.6

Elixir Capital Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 3 4 11 4 12 10 3 1 18 23 4 33
Other Income 0 0 1 0 0 0 0 0 1 1 1 1
Total Income 3 4 12 4 12 10 4 1 20 25 5 34
Total Expenditure 2 2 2 2 3 4 3 5 5 6 6 8
Operating Profit 0 2 10 2 10 6 0 -4 15 19 -1 29
Interest 0 0 0 0 0 0 0 0 1 2 1 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 -0 2 -0 -0 0 0 0 0 0 1
Profit Before Tax 0 2 9 3 9 6 -0 -5 14 17 -3 26
Provision for Tax 0 0 3 1 2 2 -0 0 1 4 1 5
Profit After Tax -0 1 7 2 7 4 -0 -5 12 13 -3 21
Adjustments 0 -0 -2 -1 -2 -1 0 1 -3 -3 1 -6
Profit After Adjustments -0 1 5 2 5 3 -0 -4 9 10 -2 15
Adjusted Earnings Per Share -0.2 1.4 8.4 2.9 8.8 5.4 -0.4 -6.6 15.7 16.5 -4.2 27

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -83% 59% -17% 3%
Operating Profit CAGR -105% 0% NAN% 0%
PAT CAGR -123% 0% NAN% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 184% 56% 26% 17%
ROE Average -10% 27% 11% 15%
ROCE Average -3% 26% 12% 18%

Elixir Capital Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 16 15 19 20 23 27 26 21 29 37 34
Minority's Interest 5 5 7 8 10 10 10 9 12 15 14
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities -0 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 2 3 2 2 3 3 2 9 32 30 19
Total Liabilities 23 24 28 30 36 40 38 39 73 83 68
Fixed Assets 6 6 6 5 5 5 5 4 4 4 4
Other Non-Current Assets 5 4 3 3 5 5 5 9 7 10 10
Total Current Assets 12 14 19 21 27 30 29 26 61 69 54
Total Assets 23 24 28 30 36 40 38 39 73 83 68

Elixir Capital Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 3 3 3 3 4 4 1 2 4 13 16
Cash Flow from Operating Activities 0 -0 1 1 -3 2 2 13 -2 5 6
Cash Flow from Investing Activities -1 0 -0 -2 3 -2 0 -9 -3 0 2
Cash Flow from Financing Activities 1 -0 -1 1 -0 -0 -2 -1 14 -2 -12
Net Cash Inflow / Outflow 0 -0 0 1 -0 0 1 2 9 3 -5
Closing Cash & Cash Equivalent 3 3 3 4 4 4 2 4 13 16 11

Elixir Capital Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -0.25 1.41 8.43 2.9 8.81 5.36 -0.36 -6.61 15.72 16.54 -4.2
CEPS(Rs) 0.09 2.78 12.22 4.96 12.72 8.06 0.31 -8.2 21.78 23 -5.32
DPS(Rs) 2.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25
Book NAV/Share(Rs) 27.34 26.77 33.16 34.01 40.38 46.47 44.06 35.35 49.34 64.17 58.27
Core EBITDA Margin(%) 15.16 48.67 83.6 46.64 78.31 62.36 3.71 -453.4 74.55 76.15 -51.53
EBIT Margin(%) 4.78 42.51 85.06 77.36 76.22 60.35 -1.24 -468.16 80.39 80.59 -40.76
Pre Tax Margin(%) 2.54 40.91 84.61 75.61 75.17 58.89 -8.48 -488.05 75.16 73.4 -70.86
PAT Margin (%) -8.44 28.72 59.75 57.14 56.4 42.22 -7.62 -539.04 67.25 56.05 -91.12
Cash Profit Margin (%) 2.12 41.32 64.04 68.02 60.35 46.89 5.21 -497.29 69.52 57.63 -82.19
ROA(%) -0.93 4.81 25.39 8.28 20.77 11 -0.67 -13.4 21.97 16.7 -4.56
ROE(%) -1.29 7.15 38.12 12.41 31.97 16.72 -1.01 -22.39 49.76 39.42 -9.64
ROCE(%) 0.7 9.76 51.16 15.68 39.59 22.42 -0.16 -18.46 43.1 36.97 -3.19
Receivable days 21.27 14.35 1.59 0.45 1.82 5.01 9.17 556.98 29.4 2.95 29.08
Inventory Days 1190.28 856.13 424.35 1395.76 620.49 965.5 2867.18 6642.46 433.37 596.15 3472.54
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 0 13.37 7.52 12.56 3.89 8.52 0 0 1.82 2.29 0
Price/Book(x) 0.95 0.7 1.91 1.07 0.85 0.98 0.81 1.04 0.58 0.59 0.59
Dividend Yield(%) 8.69 6.65 1.97 3.43 3.64 2.74 3.49 3.4 4.37 3.29 3.65
EV/Net Sales(x) 4.96 2.41 3.07 4.58 1.63 2.68 5.69 18.9 1.14 1.03 4.28
EV/Core EBITDA(x) 32.33 4.36 3.43 8.68 2.03 4.12 49.05 -4.43 1.38 1.25 -13.44
Net Sales Growth(%) 34.95 52.72 184.72 -61.76 189.02 -18.45 -65.06 -72.54 1799.94 27.4 -83.77
EBIT Growth(%) -73.71 1259.34 469.7 -65.22 184.75 -35.42 -100.72 0 426.24 27.72 -108.21
PAT Growth(%) -255.94 619.82 492.27 -63.44 185.29 -38.94 -106.31 -1842.23 337.04 6.18 -126.39
EPS Growth(%) -129.09 666.79 499.52 -65.58 203.56 -39.18 -106.79 -1717.27 337.95 5.17 -125.39
Debt/Equity(x) 0.07 0.1 0.03 0.11 0.07 0.06 0.05 0.06 0.61 0.47 0.22
Current Ratio(x) 6.26 4.84 10.58 8.96 8.25 11.21 12.04 2.87 1.91 2.31 2.81
Quick Ratio(x) 2.1 1.25 2.14 1.89 0.7 0.98 2.15 3.25 1.1 1.14 1.62
Interest Cover(x) 2.13 26.59 187.98 43.99 73.01 41.35 -0.17 -23.53 15.37 11.22 -1.35
Total Debt/Mcap(x) 0.07 0.14 0.02 0.1 0.09 0.06 0.06 0.06 1.05 0.8 0.37

Elixir Capital Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 71.29 71.29 71.29 71.29 71.29 71.29 71.29 71.29 71.29 71.29
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 28.71 28.71 28.71 28.71 28.71 28.71 28.71 28.71 28.71 28.71
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 27%
  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Elixir Capital News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!